Unified AI framework to uncover deep interrelationships between gene expression and Alzheimer’s disease neuropathologies
Preprint
Abstract
Deep neural networks offer a promising approach for capturing complex, non-linear relationships among variables. Because they require immense sample sizes, their potential has yet to be fully tapped for understanding complex relationships between gene expression and human phenotypes. Encouragingly, a growing number of diseases are being studied through consortium efforts. Here we introduce a new analysis framework, namely MD-AD ( M ulti-task D eep learning for A lzheimer’s D isease neuropathology), which leverages an unexpected synergy between deep neural networks and multi-cohort settings. In these settings, true joint analysis can be stymied using conventional statistical methods, which (1) require “harmonized” phenotypes (i.e., measured in a highly consistent manner) and (2) tend to capture cohort-level variations, obscuring the subtler true disease signals. Instead, MD-AD incorporates multiple related phenotypes sparsely measured across cohorts, and learns complex, non-linear interactions between genes and phenotypes not discovered using conventional expression data analysis methods (e.g., component analysis and module detection), enabling the model to capture subtler signals than cohort-level variations. Applied to the largest available collection of brain samples (N=1,758), we demonstrate that MD-AD learns a truly generalizable relationship between gene expression program and AD-related neuropathology. The learned program generalizes in several important ways, including recapitulation of the disease progress in animal models and across tissue types, and we show that such generalizability is not achieved by previous statistical paradigms. Its ability to identify genes with high non-linear relevance to neuropathology enabled us to identify a sex-specific relationship between neuropathology and immune response across microglia, providing a nuanced context for association between inflammatory genes and AD.Keywords
All Related Versions
- Published version: Nature Communications, 12 (1), 1.
This publication has 32 references indexed in Scilit:
- Effect of Complement CR1 on Brain Amyloid Burden During Aging and Its Modification by APOE GenotypeBiological Psychiatry, 2013
- Multiobjective evolutionary algorithms to identify highly autocorrelated areas: the case of spatial distribution in financially compromised farmsAnnals of Operations Research, 2011
- AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 2009
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's diseaseNature Genetics, 2009
- Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease?Neurochemical Research, 2007
- Adjusting batch effects in microarray expression data using empirical Bayes methodsBiostatistics, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991